Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 13 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2018 Filed Jun 12, 2018 22:58 UTC |
Lobacki Joseph MExecutive VP & CCO
|
PurchaseCommon Stock | 7,700 | $5.79 | $44,583.00 |
DisclosureSEC source: 0001104659-18-039657 · a4.xml · nonDerivative · entry 1 Lobacki Joseph M · CIK 0001536193 · Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,700 Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 22:58 UTC |
Bloom Steven H.Chief Strategy Officer
|
PurchaseCommon Stock | 3,000 | $5.98 | $17,940.00 |
DisclosureSEC source: 0001104659-18-039656 · a4.xml · nonDerivative · entry 1 Bloom Steven H. · CIK 0001722642 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Read SEC document |
| April 06, 2018 Filed Jun 4, 2018 17:56 UTC |
Le NgocDiep T. MD, PhDChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-038056 · a4.xml · derivative · entry 1 Le NgocDiep T. MD, PhD · CIK 0001719331 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2028-01-05 F1 · balance_after: On January 5, 2018, the Reporting Person was granted an option to purchase 12,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 2,500 shares. Read SEC document |
| April 06, 2018 Filed Jun 4, 2018 17:55 UTC |
Forrester RobertDirector · President and C.E.O.
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-038053 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-01-05 F1 · balance_after: On January 5, 2018, the Reporting Person was granted an option to purchase 150,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 30,000 shares. Read SEC document |
| April 06, 2018 Filed Jun 4, 2018 21:57 UTC |
Paterson DanChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-038057 · a4.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-01-05 F1 · balance_after: On January 5, 2018, the Reporting Person was granted an option to purchase 75,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 15,000 shares. Read SEC document |
| April 06, 2018 Filed Jun 4, 2018 21:56 UTC |
Bloom Steven H.Chief Strategy Officer
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-038055 · a4.xml · derivative · entry 1 Bloom Steven H. · CIK 0001722642 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-01-05 F1 · balance_after: On January 5, 2018, the Reporting Person was granted an option to purchase 70,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 14,000 shares. Read SEC document |
| April 06, 2018 Filed Jun 4, 2018 21:55 UTC |
Feder Julie BChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-038052 · a4.xml · derivative · entry 1 Feder Julie B · CIK 0001710237 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-01-05 F1 · balance_after: On January 5, 2018, the Reporting Person was granted an option to purchase 25,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 5,000 shares. Read SEC document |
| January 25, 2018 Filed Feb 13, 2019 17:02 UTC |
Forrester RobertDirector · President and CEO
|
GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000229 · edgar.xml · nonDerivative · entry 4 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 9,000 F2 · ownership.nature: Shares held by The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 25, 2018 Filed Feb 13, 2019 17:02 UTC |
Forrester RobertDirector · President and CEO
|
GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000229 · edgar.xml · nonDerivative · entry 3 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 9,000 F1 · ownership.nature: Shares held by The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 25, 2018 Filed Feb 13, 2019 17:02 UTC |
Forrester RobertDirector · President and CEO
|
GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000229 · edgar.xml · nonDerivative · entry 2 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,234 Read SEC document |
| January 25, 2018 Filed Feb 13, 2019 17:02 UTC |
Forrester RobertDirector · President and CEO
|
GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000229 · edgar.xml · nonDerivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,234 Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 17:50 UTC |
Le NgocDiep T. MD, PhDChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-001513 · a4.xml · derivative · entry 1 Le NgocDiep T. MD, PhD · CIK 0001719331 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2028-01-05 F1 · derivative.exercise_date: 25% of this option will vest on January 1, 2019 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 1, 2022. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 17:44 UTC |
Forrester RobertDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-001508 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-01-05 F1 · derivative.exercise_date: 25% of this option will vest on January 1, 2019 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 1, 2022. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:44 UTC |
Feder Julie BCFO, PFO and PAO
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-001509 · a4.xml · derivative · entry 1 Feder Julie B · CIK 0001710237 · CFO, PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-01-05 F1 · derivative.exercise_date: 25% of this option will vest on January 1, 2019 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 1, 2022. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:51 UTC |
Paterson DanChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-001514 · a4.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-01-05 F1 · derivative.exercise_date: 25% of this option will vest on January 1, 2019 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 1, 2022. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:46 UTC |
Bloom Steven H.Chief Strategy Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-001512 · a4.xml · derivative · entry 1 Bloom Steven H. · CIK 0001722642 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-01-05 F1 · derivative.exercise_date: 25% of this option will vest on January 1, 2019 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 1, 2022. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:26 UTC |
Lobacki Joseph MExecutive VP & CCO
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001104659-18-000988 · a4.xml · derivative · entry 1 Lobacki Joseph M · CIK 0001536193 · Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2028-01-03 F1 · derivative.exercise_date: 25% of this option will vest on January 3, 2019 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 3, 2022. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 16:02 UTC |
BARBERICH TIMOTHY JDirector
|
PurchaseCommon Stock | 60,538 | $3.95 | $239,125.10 |
DisclosureSEC source: 0001104659-17-072297 · a4.xml · nonDerivative · entry 1 BARBERICH TIMOTHY J · CIK 0001120355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 F1 · price: The price reported in column 4 is a weighted average priced. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.01. Upon request by the staff of the Securities and Exchange Commission, the Issuer, or security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 20:34 UTC |
Le NgocDiep T. MD, PhDChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001104659-17-061846 · a4.xml · derivative · entry 1 Le NgocDiep T. MD, PhD · CIK 0001719331 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2027-10-09 F1 · derivative.exercise_date: 25% of this option will vest on October 9, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until October 9, 2021. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 16:01 UTC |
Forrester RobertDirector · President, CEO and Director
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-17-058282 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President, CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 50,000 shares Expires 2026-06-14 F1 · balance_after: On June 14, 2016, the Reporting Person was granted an option to purchase 100,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by the end of June, 2017 and the end of June, 2018. 50% of the performance criteria was met on September 19, 2017, resulting in vesting of the option as to 50,000 shares. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:02 UTC |
Paterson DanChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-17-058284 · a4.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 50,000 shares Expires 2026-06-14 F1 · balance_after: On June 14, 2016, the Reporting Person was granted an option to purchase 100,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by the end of June, 2017 and the end of June, 2018. 50% of the performance criteria was met on September 19, 2017, resulting in vesting of the option as to 50,000 shares. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 20:46 UTC |
Stuglik Brian MDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.92 | $0.00 |
DisclosureSEC source: 0001104659-17-056340 · a4.xml · derivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-06 F1 · derivative.exercise_date: This option will vest in twelve monthly installments through September 2, 2018, with the first monthly installment vesting on October 2, 2017. Read SEC document |
| September 05, 2017 Filed Jan 24, 2024 21:00 UTC |
Rowinsky Eric KDirector
|
PurchaseCommon Stock | 2,000 | $3.84 | $7,680.00 |
DisclosureSEC source: 0001104659-24-006241 · tm244024-1_4seq1.xml · nonDerivative · entry 1 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 2,000 F1 · ownership.nature: In connection with recent divorce proceedings, Dr. Rowinsky learned of the purchase of Verastem, Inc. securities by his spouse, Lisa Slater, on September 5, 2017. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 20:37 UTC |
Feder Julie BCFO, PFO and PAO
|
GrantStock Option (Right to Buy) · Derivative | 370,000 | $0.00 Strike: $3.45 | $0.00 |
DisclosureSEC source: 0001104659-17-044509 · a4.xml · derivative · entry 1 Feder Julie B · CIK 0001710237 · CFO, PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,000 Underlying: Common Stock · 370,000 shares Expires 2027-07-10 F1 · derivative.exercise_date: 25% of this option will vest on July 10, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until July 10, 2021. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 16:22 UTC |
BARBERICH TIMOTHY JDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.09 | $0.00 |
DisclosureSEC source: 0001104659-17-039561 · a4.xml · derivative · entry 1 BARBERICH TIMOTHY J · CIK 0001120355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-06-13 F1 · derivative.exercise_date: This option will vest in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Phanstiel S. LouiseDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.09 | $0.00 |
DisclosureSEC source: 0001104659-17-039556 · a4.xml · derivative · entry 1 Phanstiel S. Louise · CIK 0001471518 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-06-13 F1 · derivative.exercise_date: This option will vest in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:20 UTC |
Rowinsky Eric KDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.09 | $0.00 |
DisclosureSEC source: 0001104659-17-039557 · a4.xml · derivative · entry 1 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-06-13 F1 · derivative.exercise_date: This option will vest in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:22 UTC |
Wendel BruceDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.09 | $0.00 |
DisclosureSEC source: 0001104659-17-039560 · a4.xml · derivative · entry 1 Wendel Bruce · CIK 0001364846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-06-13 F1 · derivative.exercise_date: This option will vest in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:21 UTC |
Kauffman MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.09 | $0.00 |
DisclosureSEC source: 0001104659-17-039559 · a4.xml · derivative · entry 1 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-06-13 F1 · derivative.exercise_date: This option will vest in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:23 UTC |
Lawton Alison FrancesDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.09 | $0.00 |
DisclosureSEC source: 0001104659-17-039562 · a4.xml · derivative · entry 1 Lawton Alison Frances · CIK 0001542650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-06-13 F1 · derivative.exercise_date: This option will vest in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017. Read SEC document |
| May 26, 2017 Filed Feb 6, 2018 19:05 UTC |
Forrester RobertDirector · President and CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-006910 · a5.xml · nonDerivative · entry 4 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By The Iona Forrester 2001 Trust Disclosed balance after: 5,000 F2 · kind: This transaction involved a gift of securities by the Reporting Person to The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 26, 2017 Filed Feb 6, 2018 19:05 UTC |
Forrester RobertDirector · President and CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-006910 · a5.xml · nonDerivative · entry 3 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,734 F2 · kind: This transaction involved a gift of securities by the Reporting Person to The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 26, 2017 Filed Feb 6, 2018 19:05 UTC |
Forrester RobertDirector · President and CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-006910 · a5.xml · nonDerivative · entry 2 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By The Claudia Forrester 2001 Trust Disclosed balance after: 5,000 F1 · kind: This transaction involved a gift of securities by the Reporting Person to The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 26, 2017 Filed Feb 6, 2018 19:05 UTC |
Forrester RobertDirector · President and CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-006910 · a5.xml · nonDerivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,734 F1 · kind: This transaction involved a gift of securities by the Reporting Person to The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 15, 2017 Filed May 17, 2017 08:21 UTC |
BARBERICH TIMOTHY JDirector
|
PurchaseCommon Stock | 30,000 | $2.45 | $73,500.00 |
DisclosureSEC source: 0001104659-17-033344 · a4.xml · nonDerivative · entry 1 BARBERICH TIMOTHY J · CIK 0001120355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,462 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.49, inclusive. Upon request by the staff of the Securities and Exchange Commission, the Issuer, or security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 17:00 UTC |
Chiapponi JosephVice President of Finance
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001104659-17-001975 · a4.xml · derivative · entry 1 Chiapponi Joseph · CIK 0001673018 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2027-01-09 F1 · derivative.exercise_date: 25% of this option will vest on January 9, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 9, 2021. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 17:00 UTC |
Forrester RobertDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 360,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001104659-17-001973 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2027-01-09 F1 · derivative.exercise_date: 25% of this option will vest on January 9, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 9, 2021. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 17:01 UTC |
Berk GregoryChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001104659-17-001976 · a4.xml · derivative · entry 1 Berk Gregory · CIK 0001306870 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2027-01-09 F1 · derivative.exercise_date: 25% of this option will vest on January 9, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 9, 2021. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 22:01 UTC |
Paterson DanChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001104659-17-001977 · a4.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2027-01-09 F1 · derivative.exercise_date: 25% of this option will vest on January 9, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 9, 2021. Read SEC document |
| October 29, 2016 Filed Nov 1, 2016 20:12 UTC |
Forrester RobertDirector · PRESIDENT AND CEO
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-16-153853 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-06-14 F1 · balance_after: On June 14, 2016, the Reporting Person was granted an option to purchase 100,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by the end of June, 2017 and the end of June, 2018. 50% of the performance criteria was met on October 29, 2016, resulting in vesting of the option as to 50,000 shares. Read SEC document |
| October 29, 2016 Filed Nov 1, 2016 20:14 UTC |
Berk GregoryCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-16-153855 · a4.xml · derivative · entry 1 Berk Gregory · CIK 0001306870 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-06-14 F1 · balance_after: On June 14, 2016, the Reporting Person was granted an option to purchase 100,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by the end of June, 2017 and the end of June, 2018. 50% of the performance criteria was met on October 29, 2016, resulting in vesting of the option as to 50,000 shares. Read SEC document |
| October 29, 2016 Filed Nov 2, 2016 00:13 UTC |
Paterson DanCHIEF OPERATING OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-16-153854 · a4.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-06-14 F1 · balance_after: On June 14, 2016, the Reporting Person was granted an option to purchase 100,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by the end of June, 2017 and the end of June, 2018. 50% of the performance criteria was met on October 29, 2016, resulting in vesting of the option as to 50,000 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.